홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
CALC
#3866
CalciMedica, Inc. Common Stock
0.5
2
-7.14%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-7.14%
월간 변동
-38.10%
6달 변화
-82.07%
년간 변동율
-78.78%
이전 종가
0.5
6
Open
0.5
2
Bid
Ask
Low
0.5
2
High
0.5
2
양
4
마켓
주식
헬스케어
CALC
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
13.48 M
13.48 M
13.97 M
13.97 M
14.26 M
—
Valuation ratios
Enterprise value
50.57 M
39.79 M
14.13 M
16.44 M
—
—
Price to earnings ratio
0.26
-2.9
-1.16
-0.96
-1.86
-6.89
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
1.92
1.88
1.05
0.97
1.99
5.89
Price to book ratio
0.79
2.76
0.47
0.49
1.24
4.96
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.33
-0.22
-0.2
-0.31
-0.52
-1.25
Return on equity %
0.59
-0.3
-0.46
-0.98
-29.12
-30.85
Return on invested capital %
-2 013.51
-2 593.28
-3 244.44
-3 917.75
-2 623.7
-12.38 K
Gross margin %
—
—
100
100
100
—
Operating margin %
—
—
-3 216.34
-3 009.55
-4 012.86
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
-2 496.04
-2 707.27
-5 574.29
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
4.15
5.34
5.66
5.45
4.04
20.48
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
0.01
0.01
0.01
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.44
-0.44
-0.35
-0.46
-0.32
-1.57
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.37
1.66
1.74
1.24
0.96
5.6
Net current asset value per share
1.47
1.75
1.79
1.3
1.01
5.84
Tangible book value per share
0.85
1.28
0.77
0.42
-0.02
2.45
Working capital per share
1.12
1.42
1.47
1.06
0.76
4.71
Book value per share
0.85
1.28
0.77
0.42
-0.02
2.45
뉴스
칼시메디카, 임상 중단 후 H.C. Wainwright, ’중립’으로 등급 하향
CalciMedica stock downgraded to Neutral by H.C. Wainwright after trial halt
칼시메디카, 2상 KOURAGE 임상시험 중단 권고에 따라 중단
CalciMedica discontinues Phase 2 KOURAGE trial following committee recommendation
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.02%
칼시메디카, 신장 손상 임상 중단 후 주가 폭락
칼시메디카, 안전 문제로 AKI 임상시험 중단
CalciMedica discontinues AKI trial following safety concerns
CalciMedica Pauses Kidney Study, Eyes New Trial In Pancreatitis - CalciMedica (NASDAQ:CALC)
Oppenheimer reiterates Outperform rating on CalciMedica stock ahead of key trial
CalciMedica partners with Telperian to use AI for clinical trial analysis
칼시메디카 CBO, 7,675달러 상당 자사주 매입